BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22248059)

  • 1. Overexpression of Yin Yang 1 in the pathogenesis of human hematopoietic malignancies.
    Bonavida B; Huerta-Yepez S; Baritaki S; Vega M; Liu H; Chen H; Berenson J
    Crit Rev Oncog; 2011; 16(3-4):261-7. PubMed ID: 22248059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
    Huerta-Yepez S; Liu H; Baritaki S; Del Lourdes Cebrera-Muñoz M; Rivera-Pazos C; Maldonado-Valenzuela A; Valencia-Hipolito A; Vega MI; Chen H; Berenson JR; Bonavida B
    Int J Oncol; 2014 Sep; 45(3):1184-92. PubMed ID: 24970600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic role of Yin Yang 1.
    Zhang Q; Stovall DB; Inoue K; Sui G
    Crit Rev Oncog; 2011; 16(3-4):163-97. PubMed ID: 22248053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
    Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic potential of yin yang 1 mediated through control of imprinted genes.
    Thiaville MM; Kim J
    Crit Rev Oncog; 2011; 16(3-4):199-209. PubMed ID: 22248054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
    Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
    Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription regulator Yin-yang 1: from silence to cancer.
    Zhu W; Olson SY; Garbán H
    Crit Rev Oncog; 2011; 16(3-4):227-38. PubMed ID: 22248056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
    Kaufhold S; Garbán H; Bonavida B
    J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia.
    Beck K; Wu BJ; Ni J; Santiago FS; Malabanan KP; Li C; Wang Y; Khachigian LM; Stocker R
    Circ Res; 2010 Dec; 107(12):1490-7. PubMed ID: 21030713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yin Yang 2: the great unknown within the Yin Yang 1 regulatory network.
    Klar M
    Crit Rev Oncog; 2011; 16(3-4):239-43. PubMed ID: 22248057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Yin and Yang of YY1 in tumor growth and suppression.
    Khachigian LM
    Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional transcription factor YY1: a therapeutic target in human cancer?
    Wang CC; Chen JJ; Yang PC
    Expert Opin Ther Targets; 2006 Apr; 10(2):253-66. PubMed ID: 16548774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin Yang 1 in human cancer.
    Nicholson S; Whitehouse H; Naidoo K; Byers RJ
    Crit Rev Oncog; 2011; 16(3-4):245-60. PubMed ID: 22248058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
    Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
    Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (
    Antonio-Andrés G; Rangel-Santiago J; Tirado-Rodríguez B; Martinez-Ruiz GU; Klunder-Klunder M; Vega MI; Lopez-Martinez B; Jiménez-Hernández E; Torres Nava J; Medina-Sanson A; Huerta-Yepez S
    Leuk Lymphoma; 2018 Nov; 59(11):2628-2638. PubMed ID: 29616858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological implications of Yin Yang 1 in the hallmarks of cancer.
    Meliala ITS; Hosea R; Kasim V; Wu S
    Theranostics; 2020; 10(9):4183-4200. PubMed ID: 32226547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.
    Cho AA; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):49-61. PubMed ID: 29604936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
    Baritaki S; Katsman A; Chatterjee D; Yeung KC; Spandidos DA; Bonavida B
    J Immunol; 2007 Oct; 179(8):5441-53. PubMed ID: 17911631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multilayered Regulation of the Oncogenic Protein YY1.
    Rizkallah R; Hurt MM
    Crit Rev Oncog; 2017; 22(1-2):109-129. PubMed ID: 29604940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Forgotten YY2 in Reported YY1 Expression Levels in Human Cancers.
    Kaufhold S; Aziz N; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):63-73. PubMed ID: 29604937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.